Acadian Asset Management LLC Infla Rx N.V. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.11 - $3.25 $20,899 - $32,191	9,905 Added 104.27%	19,404 $60,000
Q3 2022 Nov 14, 2022	BUY	$1.32 - $3.14 $12,538 - $29,826	9,499 New	9,499 $25,000
Q3 2022 Nov 14, 2022	BUY	$1.32 - $3.14 $12,538 - $29,826	9,499 New	9,499 $25,000
Q1 2021 May 11, 2021	SELL	$3.62 - $6.34 $22,914 - $40,132	-6,330 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$3.82 - $5.32 $24,180 - $33,675	6,330 New	6,330 $32,000
Q3 2019 Nov 07, 2019	SELL	$2.47 - $3.51 $347,776 - $494,207	-140,800 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$3.06 - $51.61 $430,848 - $7.27 Million	140,800 New	140,800 $445,000

13.2M

5.2K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $69.8M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.